Reversal of adynamic bone disease by lowering of dialysate calcium (Q57221775)

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Parathormone secretion in peritoneal dialysis patients with adynamic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Prevention of renal osteodystrophy in peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Is aplastic osteodystrophy a disease of malnutrition?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Renal osteodystrophy in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Reduced calcium dialysate in CAPD patients: efficacy and limitations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Calcium balance during pulse alfacalcidol therapy for secondary hyperparathyroidism in CAPD patients treated with 1.0 and 1.25 mmol/L dialysate calcium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Evidence for abnormal calcium homeostasis in patients with adynamic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Pathogenesis, prevention and management of low-bone turnover.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Managing phosphate retention: is a change necessary?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Cardiac Valve Calcification as an Important Predictor for All-Cause Mortality and Cardiovascular Mortality in Long-Term Peritoneal Dialysis Patients: A Prospective Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Vascular calcification in ESRD: Another cloud appears in the perfect storm--but highlights a silver lining?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Risk factors for vertebral fractures in renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021

Can unequal be more fair? A response to Andrew Avins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001666

7 January 2021